Open Access

EDITORIAL

Leonard G. Gomella
Canadian Journal of Urology, Vol.31, No.6, pp. 12030-12031, 2024
Abstract This article has no abstract. More >

View

54

Download

48

Open Access

LEGENDS IN UROLOGY

Francesco Montorsi
Canadian Journal of Urology, Vol.31, No.6, pp. 12032-12034, 2024
Abstract This article has no abstract. More >

View

44

Download

41

Open Access

REVIEW

Gabrielle R. Yankelevich¹, Kale Moreland², Makayla M. Swancutt², Robert L. Grubb¹
Canadian Journal of Urology, Vol.31, No.6, pp. 12035-12044, 2024
Abstract Introduction: We report the first scoping review of the clinical urologic literature for photodynamic therapy (PDT) among multiple urologic malignancies.
Materials and methods: A scoping review using Medline and Embase was performed for treatment of urologic malignancies with PDT.
Results: There were 84 papers included with the majority involving bladder and prostate cancer. Upper tract urothelial cancer (UTUC) only comprised three publications and there was no clinical data for renal or testicular cancer. Utilizing PDT in prostate cancer led to a negative biopsy rate of 30%-100%. Bladder cancer treatment with PDT had a 3-month complete response rate of More >

View

33

Download

33

Open Access

ARTICLE

Alon Lazarovich¹, Daniel R. Greenberg², Stephen P. Rhodes³, Hriday P. Bhambhvani⁴, Luis C. Gago², Hiten D. Patel², Robert E. Brannigan², Jonathan E. Shoag⁵, Joshua A. Halpern²
Canadian Journal of Urology, Vol.31, No.6, pp. 12045-12052, 2024
Abstract Introduction: To determine the prevalence of hypogonadism in men undergoing partial nephrectomy (PN) and whether hypogonadism and frailty are associated with adverse postoperative outcomes.
Materials and methods: We identified men undergoing PN between 2012-2021 using the Merative Marketscan database. Patients were considered to have hypogonadism if diagnosed within 5 years prior to PN. Frailty was determined using the Hospital Frailty Risk Score (HFRS). Length of stay (LOS), complications, ED visits, and inpatient readmissions were compared. Sub-group analysis of men with hypogonadism was performed to determine if testosterone replacement therapy (TRT) improved clinical outcomes.
Results: Among 9,105 men who… More >

View

37

Download

30

Open Access

ARTICLE

Joshua Winograd^1,*, John Lama^1,*, Alia Codelia-Anjum², Naeem Bhojani³, Dean S. Elterman⁴, Kevin C. Zorn^3,5, Eric Margolis⁶, Jamin Brahmbhatt⁷, Ricardo Gonzalez⁸, Bilal Chughtai²
Canadian Journal of Urology, Vol.31, No.6, pp. 12053-12059, 2024
Abstract Introduction: Benign prostatic hyperplasia (BPH) is a prevalent condition affecting a significant portion of the male population, leading to secondary lower urinary tract symptoms (LUTS). Alternative therapies such as phytotherapy using Lipidosterolic extract of Serenoa repens (LSESR USPlus) are commonly used. However, the efficacy of LSESr remains controversial due to conflicting data. We sought to determine the effect of a standardized USP-verified Saw Palmetto extract on male LUTS secondary to BPH.
Materials and methods: In this prospective single arm trial, we investigated the efficacy of a standardized USP-verified Saw Palmetto extract in treating male LUTS secondary to More >

View

28

Download

37

Open Access

ARTICLE

Jacob Grassauer¹, Wesley H. Chou², Anna Geduldig¹, Jackson Schmidt², Nicholas H. Chakiryan^1,2,3,4
Canadian Journal of Urology, Vol.31, No.6, pp. 12060-12071, 2024
Abstract Introduction: It is unclear whether laterality has prognostic implications for patients with renal cell carcinoma (RCC). Some suggest that left sided tumors may have worse survival outcomes. The purpose of this study is to associate tumor characteristics and clinical outcomes with laterality in patients with RCC.
Materials and methods: Patients with RCC were identified in the National Cancer Database between 2004-2020. Patients were categorized as having either localized, regional or metastatic disease. Time-series charts were generated to demonstrate laterality differences and variance over time. Multivariable Cox proportional hazards regression was utilized to associate laterality with overall survival, stratified… More >

View

37

Download

29

Open Access

ARTICLE

Alex J. Xu¹, Jeffery S. Lin¹, Po Yen Chen², Samuel Carbunaru¹, Yeonsoo S. Lee³, Lee C. Zhao¹
Canadian Journal of Urology, Vol.31, No.6, pp. 12072-12076, 2024
Abstract Introduction: We describe a method of robotic ureterocalicostomy (RALUC) with the Da Vinci Single Port (SP) platform and present clinical outcomes in our cohort of patients.
Materials and methods: We retrospectively reviewed all patients undergoing RALUC with the SP platform in a single-institution, IRB-approved database between 2020 2023. Demographics, preoperative, intraoperative, and postoperative outcomes were collated. Surgical success was defined as freedom from hardware, avoidance of additional surgical reconstruction, and no obstruction on follow up imaging/ureteroscopy.
An incision is made 1/3rd the distance from anterior superior iliac spine to the umbilicus. The retroperitoneal space is entered and SP… More >

View

41

Download

43

Open Access

RESIDENT’S CORNER

Stephanie Aron, Anthony Galvez, Ryan Nasseri, Susana Berrios, Tyler Sheetz
Canadian Journal of Urology, Vol.31, No.6, pp. 12077-12080, 2024
Abstract Nephrolithiasis is one of the most common indications for surgery in patients with a horseshoe kidney. Robotic assisted surgery has become a staple in urologic practice, yet its application in stone management is largely undefined. We present a patient with a horseshoe kidney, who underwent a robotic-assisted laparoscopic pyelolithotomy (RPL) to treat a 3 cm stone burden. This procedure allowed for safe access that could not be obtained with percutaneous nephrolithotomy (PCNL) and stone removal without fragmentation, which would have been challenging with traditional laparoscopy. We advocate for the use of robotic-assisted laparoscopic pyelolithotomy in More >

View

35

Download

36